Robert S. Willoughby

Food and Drug Administration

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline – LPCN | Globe Newswire | 12/3/2019

… Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980 … both times, received Complete Response Letters (“CRL”) from the U.S. Food and Drug Administration (“FDA”) rejecting the NDAs. The Company received the first CRL in June 2016 and the second in May 2018. On March …

Follow Robert S. Willoughby:    

Henry Schein

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Covetrus, Inc. - CVET | Globe Newswire | 11/20/2019

Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether Covetrus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] Covetrus was formed through a spin-off and merger of the Animal Health Business of Henry Schein with Vets First Choice, a privately-held company. On August 13 …

GeneSight

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – MYGN | Globe Newswire | 11/20/2019

Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Myriad is a molecular diagnostic company that develops and markets predictive, personalized, and prognostic medicine tests worldwide. Myriad offers, among other products, GeneSight, a DNA …

Fresenius Medical Care

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA – FMS | 11/16/2019

Content Marketing & Distribution News Release Broadcast What We Do Newsroom Contact Us SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA – FMS NEW YORK, NY / ACCESSWIRE / November 16, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA (“Fresenius” or the “Company”) (NYSE:FMS). Such investors are advised to contact Robert S. Willoughby at …

Myriad Genetics

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – MYGN | Globe Newswire | 11/12/2019

… 2019 18:24 ET Source: Pomerantz LLP NEW YORK, Pomerantz LLP announces that a class action lawsuit has been filed against Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Abeona Therapeutics

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO | Globe Newswire | 11/8/2019

… LLP NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

electroCore

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in electroCore, Inc. of Class Action Lawsuit and Upcoming Deadline – ECOR | Globe Newswire | 11/6/2019

… LLP NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP announces that a class action lawsuit has been filed against electroCore, Inc. (“electroCore” or the “Company”) (NASDAQ: ECOR) and certain of its officers. The class … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Clinical Data

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of electroCore, Inc. - ECOR | Globe Newswire | 10/16/2019

… claims on behalf of investors of electroCore, Inc. (“electroCore” or the “Company”) (NASDAQ: ECOR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether electroCore … and Drug Administration had requested additional information and analysis of clinical data in connection with electroCore’s 510(k) submission seeking an expanded indication for the use of gammaCore, the Company’s lead product. On this news …

Nektar Therapeutics

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR | Globe Newswire | 10/16/2019

October 15, 2019 17:55 ET Source: Pomerantz LLP NEW Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether Nektar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information …

Sarepta Therapeutics

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT | Globe Newswire | 10/15/2019

… LLP NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Curaleaf

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Curaleaf Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - CURLF | Globe Newswire | 10/1/2019

… 2019 19:47 ET Source: Pomerantz LLP NEW YORK, Pomerantz LLP announces that a class action lawsuit has been filed against Curaleaf Holdings, Inc. (“Curaleaf” or the “Company”) (OTCMKTS: CURLF) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Abiomed

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ABIOMED, Inc. of Class Action Lawsuit and Upcoming Deadline – ABMD | Globe Newswire | 10/1/2019

… 2019 19:43 ET Source: Pomerantz LLP NEW YORK, Pomerantz LLP announces that a class action lawsuit has been filed against ABIOMED, Inc. (“ABIOMED” or the “Company”) (NASDAQ: ABMD) and certain of its officers. The class … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Cardinal Health

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH | The Wapakoneta Daily News | 9/27/2019

NEW YORK, Sept. 27, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) ( NYSE: CAH ). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether Cardinal Health and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for …

Aclaris

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ACRS | PR Newswire | 9/26/2019

NEW YORK , Sept. Pomerantz LLP announces that a class action lawsuit has been filed against Aclaris Therapeutics Inc. (“Aclaris” or the “Company”) (NASDAQ: ACRS ) and certain of its officers. The class action, filed in United … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Aclaris Therapeutics

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ACRS | PR Newswire | 9/26/2019

NEW YORK , Sept. Pomerantz LLP announces that a class action lawsuit has been filed against Aclaris Therapeutics Inc. (“Aclaris” or the “Company”) (NASDAQ: ACRS ) and certain of its officers. The class action, filed in United … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Continuum of Care

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ABIOMED, Inc. of Class Action Lawsuit and Upcoming Deadline – ABMD | Globe Newswire | 9/24/2019

… Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980 … the pumping function of the failing heart, and also provides continuum of care to heart failure patients. ABIOMED offers, among other things, catheters and micro heart pumps under the Impella brand with integrated motors and …

Karyopharm Therapeutics

Pomerantz Law Firm Announces the Filing of a Class Action against Karyopharm Therapeutics Inc. and Certain Officers – KPTI | Globe Newswire | 9/17/2019

… 2019 19:44 ET Source: Pomerantz LLP NEW YORK, Pomerantz LLP announces that a class action lawsuit has been filed against Karyopharm Therapeutics Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

BeiGene

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of BeiGene, Ltd. – BGNE | 9/14/2019

Content Marketing & Distribution News Release Broadcast What We Do Newsroom Contact Us SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of BeiGene, Ltd. – BGNE NEW YORK September 13, 2019 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of BeiGene, Ltd. (“BeiGene” or the “Company”) (NASDAQ: BGNE). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 9980. The investigation concerns whether BeiGene

Omnicell

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL | Benzinga | 9/12/2019

Pomerantz LLP is investigating claims on behalf of investors of Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether Omnicell and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 11, 2019 …

Helius Medical Technologies

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Helius Medical Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline - HSDT | Globe Newswire | 9/7/2019

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP announces that a class action lawsuit has been filed against Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …